HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gonadal function in children with nephrosis treated with cyclophosphamide.

Abstract
Conadal function was evaluated in 23 boys and 11 girls treated with cyclophosphamide, 2 to 5 mg/kg/day for periods of 1.5 to 6 months. Serum follicle stimulating hormone (FSH), luteinizing hormone (LH), and testosterone levels were determined by radioimmunoassay. All 16 boys treated when prepubertal or during early puberty had normal, FSH, LH, and testosterone levels. Testicular biopsy was performed in five of the 16, and was abnormal in four and normal in one. Sperm count was normal in two other patients. The remaining seven boys were treated when pubertal; all have decreased spermatogenesis, and five of them have increased FSH levELS. The LH and testosterone levels were normal. No evidence of gonadal dysfunction was detected in any of the girls. Of four patients treated when postpubertal, three have become pregnant.
AuthorsA J Pennisi, C M Grushkin, E Lieberman
JournalAmerican journal of diseases of children (1960) (Am J Dis Child) Vol. 129 Issue 3 Pg. 315-8 (Mar 1975) ISSN: 0002-922X [Print] United States
PMID1121961 (Publication Type: Journal Article)
Chemical References
  • Testosterone
  • Cyclophosphamide
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
Topics
  • Adolescent
  • Adult
  • Biopsy
  • Cell Count
  • Child
  • Child, Preschool
  • Cyclophosphamide (administration & dosage, adverse effects, therapeutic use)
  • Female
  • Follicle Stimulating Hormone (blood)
  • Follow-Up Studies
  • Gonads (drug effects)
  • Humans
  • Luteinizing Hormone (blood)
  • Male
  • Nephrosis (drug therapy)
  • Radioimmunoassay
  • Sex Characteristics
  • Spermatogenesis (drug effects)
  • Spermatozoa
  • Testis
  • Testosterone (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: